Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3524636019 | Product containing raltitrexed (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3716423014 | Raltitrexed-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing raltitrexed | Is a | Product containing antifolate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing raltitrexed | Has active ingredient | Raltitrexed | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing raltitrexed | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing raltitrexed | Is a | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing raltitrexed | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection | Is a | False | Product containing raltitrexed | Inferred relationship | Existential restriction modifier | |
| Product containing raltitrexed in parenteral dose form (medicinal product form) | Is a | True | Product containing raltitrexed | Inferred relationship | Existential restriction modifier | |
| Raltitrexed | Is a | True | Product containing raltitrexed | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR